FCMT
GMAB icon

Founders Capital Management (Texas)’s Genmab GMAB Stock Holding History

Founders Capital Management (Texas)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.5K Hold
1,400
– – 0.02% 185
2026
Q1 		$37.6K Hold
1,400
– – 0.02% 174
2025
Q4 		$43.1K Buy
1,400
+400
+40% +$12.5K 0.02% 154
2025
Q3 		$30.7K Hold
1,000
– – 0.02% 189
2025
Q2 		$20.7K Buy
+1,000
New +$20.5K 0.01% 231

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Founders Capital Management (Texas)'s GMAB Position: Q2 2026 in Review

Founders Capital Management (Texas) held its Genmab (GMAB) position steady in Q2 2026 at 1,400 shares worth $38.5K. The position accounts for 0.02% of the portfolio, ranked #185.

Founders Capital Management (Texas) first reported a position in GMAB in Q2 2025 and has held it in 5 quarters since. The position peaked at $43.1K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Founders Capital Management (Texas) held 1,400 shares of Genmab worth $38.5K as of Q2 2026.
  • Founders Capital Management (Texas) left its Genmab share count unchanged in Q2 2026.
  • Genmab made up 0.02% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #185 holding.
  • Founders Capital Management (Texas) first reported a position in Genmab in Q2 2025 and has held it in 5 quarters since.
  • Founders Capital Management (Texas)'s Genmab position peaked at $43.1K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.